HEMORAAS^®
Human Coagulation Factor Ⅷ

• On Sale Specifications

  Freeze-dried powder injection

  100IU；200IU；250IU；300IU；400IU；500IU；1000IU.

• Indications

  This product has a corrective effect on coagulation dysfunction caused by deficiency of human coagulation factor VIII, and is mainly used for the prophylaxis and treatment of hemophilia A  and cure of bleeding symptoms caused by and acquired coagulation factor VIII deficiency and surgical bleeding in such patients.